Home >> Top News >> FDA clears Ortho’s Vitros XT 7600 Integrated System

FDA clears Ortho’s Vitros XT 7600 Integrated System

Print Friendly, PDF & Email

Nov. 5, 2018Ortho Clinical Diagnostics received FDA clearance for its Vitros XT 7600 Integrated System. The Vitros XT 7600 uses the company’s Digital Chemistry technology, which combines microslide technology, digital imaging, and dry slide technology.

“It’s an exciting time for clinical labs, and today’s clearance of Ortho’s Vitros XT 7600 System represents a fundamental improvement in the way labs can operate, now and in the future,” Jennifer Paine, Ortho’s chief product portfolio officer, said in a press release. “Vitros XT 7600, along with Digital Chemistry, harnesses the power of our proprietary dry slide technology to deliver high-quality test results and higher throughput—all within the lab’s existing physical footprint.”

The Vitros XT 7600 will introduce multitest processing (in development), which will allow the instrument to simultaneously perform tests that are frequently ordered for the same patient, reducing the amount of patient sample required.

x

Check Also

Ortho, EKF collaborate on BHB assay, 2/18

February 2018—Ortho Clinical Diagnostics and EKF Diagnostics announced an agreement that allows Ortho customers to access EKF’s Beta-Hydroxybutyrate LiquiColor Assay, a CLIA moderate-complexity test for use on Ortho’s Vitros 4600 Chemistry System and Vitros 5600 Integrated System.

X